INTRODUCTION
This research study is a three-part project planned to be co nducted over three years to validate the accuracy and reliability of using Near Infrared Spectroscopy (NIRS) to diagnose acute compartment syndrome (ACS) in combat soldiers and civilians sufferring high energy trauma to the lower extremities. Part 1 was to be two clinical observational studies. The first part (Phase I) was conducted at Landstuhl Regional Medical Center and was started in the first year of this award and completed on budget. The second study (Phase 2) was originally planned to be conducted in theater at Level III CSHs in Afghanistan and Iraq with support from the Joint Combat Casualty Research Team (JC2RT) and a researcher who specifically deployed to lead this study intheater. However, during the protocol review process, USAMRMC petitioned for a pre-IDE determination from the FDA, and it was decided that the study needed to be conducted as an FDA-regulated study (with "abbreviated requirements"), and was transitioned to three civilian hospitals in the state of Georgia. This transition caused over 12 months delay in initiating the study, as described in our previous annual report. Because of this delay, we are seekin g an extension for this award into a fourth year and if awarded, we will be on track for completing enrollment in the Phase 2 study by the third quarter of this f ourth year, which will mark successful completion of all original tasks for this grants Statement of Work. Part 2 (Task 3) of this award uses porcine models of ACS to further eval uate and validate the clinical utility of using continuous NIRS monitoring to diagnose ACS. The initial experiments using albumin infusion and contusion/albumin infusions models for inducing ACS were successfully completed on target by the end of the second year of this grant. These studies demonstrated that NIRS measurement of hemoglobin oxygen saturation in the tibial compartment provided reliable and sensitive correlation to increases and decreases in intra-compartment pressure and intra-compartment perfusion pressure. This year we have built on the success of the animal e xperiments by employin g a se cond model of tibial compartment syndrome which uses an inflatable balloon to increase intra-compartment pressure.
The final part of this project (Tasks 4-6) will include the translation of the current technology into a proven means for detecting the presence of critical hypoperfusion of the leg compartments indicative of acute compartment syndrome. The data collected in our Phase 1 and 2 clinical studies and the animal studies will be used to develop a diagnostic algorithm, and ultimately form the basis for a subsequ ent clinical trial to valida te this algorithm and lead to the first FDA indicated diagnostic device for ACS. The current FDA approved indication for the NIRS device used in our clinical studies (the Nonin Equanox TM 7600 oximeter) is for monitoring regional tissue oxygenat ion. This device has been validated and is currently marketed as a means for detecting altered states of perfusion in normal (i.e. not traumatically injured, specifically cerebral) tissue. Our research is pushing this technology to its limits, by seeking to monitor altered perfusion states in abnormal (i.e. traumatically injured) tissue. In this Period and Period 4, our industry partner and this research team have sought and will continue to identify areas to improve this technology in the reduction to practice of a ACS diagnostic d evice. The FDA indication we will seek to develop, submit and defend using the results of the clinical and animal studies conducted under this grant and the subsequently planned clinical study is a diagnostic indication such that the device can be approved to provide information that directly impacts clinical decision making. This function will meet the critical unmet need in combat casualty care originally identified in our grant proposal.
BODY
The primary goal of work conducted in Period 3 was to establish the Phase 2 clinical study at three sites in the state of Georgia, and to start subject enrollment. This has been accomplished and we are on target to complete subject enrollment within the first three quarters of the potentially extended Period 4. 2d: Conduct Phase 2 Prospective Observational Study As discu ssed in our pre vious annual report, this study was originally planned to be conducted in theater in Afghanistan and Iraq, but due to decisions by the USAMRMC and FDA, the study had to be transitioned to the civilian setting. This caused a 12+ month setback in our timeline, but we are seeking a one year extension, and a budget increase to provide for this transition and completion of this study in the civilian setting.
At the end of the previous period, three sites had been selected in Georgia -Grady Memorial Hospital (GMH), Atlanta Medical Center (AMC) and Athens Regional Medical Center (ARMC). During the current Period we have successfully established rese arch teams covering all the sites, implemented study-related procedures, data collection and management procedures, trained the research teams, obtained IRB and HRPO approval to conduct the study at these sites, trained the hospital staff at each center on the study, established and implemented an FDA-compliant medical monitoring program and begun enrolling subjects. Issues and setbacks were encounte red along the way but solutions were implemented as described in this annual report and this Period's quarterly reports, and we are still on track f or a successful completion of this study before the end of the third quarter of Period 4. Major milestones achieved for each site are outlined in Table 1 .
Site
Initial IRB Approval Initial HRPO Approval Patients that meet most eligibility criteria are then followed up on to complete screening, determine eligibility and request consent from the patient or from a legally authorized representative if the patient is not capable of providing consent on their own behalf. To date, 379 patients admitted to the ICU with trauma have been screened (F igure 1) and 19 have been enrolled out of a total cohort requirement of 25 subjects ( Table 2) . However, five of these subjects were withdrawn before NIRS monitoring commenced because they were subsequently deemed in eligible, or consent was withdrawn. Additionally, two subjects withdrew consent after two or four hours of monitoring. Consequently, an extended period of NI RS monitoring has been captured for 12 Cohort 1 subjects. In the next Period we will extend the Cohort 1 size by 7 additi onal patients, to insure we have complete data sets for a total number of 25 subjects in this cohort.
As illustrated in Figure 1 , the most frequent reason potential Cohort 1 patients were excluded accounting for 38.3% of all patients screened (145 of 379 patients) was because their expected length of stay was less than 48 hours. Most of these patients w ere admitted to the ICU for observation following a concussion, or were not critically injured. A few were very critically injured and were not expected to survive. The age of the patient not falling within the 18 to 65 year range was the next most frequent reason for exclusion (65 patients, 17.2%) or that they had bony or vascular injuries to their lower extremities (44 patients, 14.5%). Forty-two patients were excluded for reasons not outlined in the eligibility criteria, but they were considered unsuitable research candidates. The majority of these patients were combative or uncooperative to their medical care, or they had significant psychological problems or severe comorbidities.
Screening and Enrollment -Cohorts 2 and 3 Cohort 2 subjects are patients with tibia/fibula shaft or tibial plateau fractures that are caused by high energy impacts and are therefore likely to develop ACS. All patients admitted to participating hospitals with tibia fractures are screened for inclusion. Coordinators are notified by the treating resident of all admissions potentially meeting eligibility criteria, and the coordinators do the detailed screening. Cohort 3 (previously called Cohort 2C) subjects are Cohort 2 subject s that subsequently are clinically diagnosed with ACS, receive surgical fasciotomies to treat the ACS, and move from Cohort 2 to Cohort 3.
Screening for Cohort 2 began in March 2012 at GMH, but was placed on hold through April and May for further refinement of procedures and training of coordinators and hospital staff. Screening began at AMC and ARMC in August. By the end of the current Period 3, 95 patients with tibia fractures had been screened ( Figure 2 ) and 31 subjects had been enrolled (Table 2 ) out of the 95 required by the protocol. Of these only one patient developed ACS and moved into Cohort 3. The most frequent reasons for patients to fail screning was that their fractures did not meet the severity criteria set forth in the protocol (18 patients, 19.6%) or they could not be consented and enrolled within 12 hours of their injuries (12 patients, 13.%). The issue of required informed consent for this no greater than minimal risk pro tocol, using a nonsignificant risk medical device, has been a known significant problem, and was the core issue related to the transi tion of Phase 2 from a military combat setting to the civilian trauma centers. This is a problem t hat is outside our control, yet we have sought all options to mitigate its im pact. For example, most of the latter patients were identified earlier in the recruitment process and the coordinators were not notified of the patient immediately. Further training of the providers and research team has greatly reduced the number of potential patients lost. A manuscript was also prepared a nd was sub mitted to Th e Journal of Orthopedic Trauma. Copies of these abstracts and manuscript are included in this Annual Report as Appendix A.
GMH

TASK 3: Animal Use Study -Second Porcine Study
After successful completion of the albumin infusion and contusion/albumin infusion models, a third porcine model was developed and implemented, based on work from the US Army Institute of Surgical Research. The new model is a tibial compartment syndrome model that produces consistent intra-compartmental muscle swelling, microvascular compromise and tissue hypoperfusion as well as predictable extensive tissue damage. The injury model is created by inserting a balloon catheter between the anterior muscle compartment and the anterior face of the tibia. This is a reperfusion model of ACS. Baseline NIRS values and tibial intracompartmental pressure (TICP) are measured then a compartment syndrome injury is created by inflating the balloon catheter with saline to sustain TICP at 30 mmHg above mean arterial pressure which is sustained for 6 hours. After 6 hours, the balloon is deflated, allowing for reperfusion of the compartment. Tissue oxygenation was monitored continuously using NIRS, and TICP was assessed for the duration of the 6 hour induction of compartment syndrome and the 8 hour reperfusion and recovery period. This study is also contracted to the University of Georgia (UGA) College of Veterinary Medicine and is being completed under a no-cost extension.
3a: Created UGA IACUC Protocol Application for Animal Studies During the current year, the protocol for the reperfusion porcine study was developed and submitted to the UGA IACUC.
3b: Obtain UGA IACUC and USAMRMC ACURO Approvals for Second Study The UGA IACUC approved the protocol on 02/08/2012. It was submitted to the USAMRMC ACURO and received their approval on 02/24/2012.
3c and d: Initiate and Conduct Animal Studies
The reperfusion pig study was conducted and completed on time in the third quarter of this perf ormance year. Nine animals were used in the study, seven of which produced usable data to be included in the final analysis. The results of the experiment indicated that while intra-compartmental pressure increases with muscle damage, there is not a complete loss of tissue oxygen saturation in the tissue over the 14 hours of the protocol.
In the fina l quarter of P eriod 3 we began planning the last of the anim al studies, in which we plan to evaluate the NIRS re sponse to a "missed" compartment syndrome. This model will use NIRS to monitor the changes that take place when a fasciotomy is performed too late and muscle has died. This study will be initiated in the 1 st quarter of the 4 th period under a no-cost extension at UGA, if awarded. 3e and f: Analyze Data and Prepare for Presentation and Publication This work is underway at the end of this performance period and will be continued into the fourth year. Ongoing -The current embodiment, more specifically the spectroscopy technology is mature and ideal for our intended indication. In this light, we feel we have a final prototype. There are still planned small physical improvements, for example, increasing the number of ports per machine, but these improvements will not affect the results of our planned studies.
4d: Respond to provider feedback re: functionality and industrial design -Completed. In our experience with the device, the only two significant physical improvements needed are the addition of more ports to a single machine, so that a singl e patient can be monitored by a single machine, and "horse-tailing" of leads, such that 4 sensors connect to a single cable about 1 foot or less from the patients leg and that cable then runs back to the device, to cut down on cable clutter in the current system. Both of these changes are small and will not affect our results. To get broader feedback, we have included provider feedback into the CRF for the Phase 2 study. The primary product development piece to occur over the course of this grant and in work to follow the conclusion of this grant will be the development and then validation of a diagnostic algorithm, for which a new FDA indication will be applied that approves the use of this device as a diagnostic tool for acute compartment syndrome. 5c: Rapid interpretation of weakness in the design and function of sequential NIRS pad prototypes and NIRS monitoring algorithms. -Ongoing. The device is in a state where it is and has been fully ready for testing in our studies. It will probably undergo some minor physical improvements with time. The major improvement will be the design and validation of a diagnostic algorithm based on NIRS values. This process is ongoing and will continue past our grant period. This process will ultimately require validation in a prospective interventional trial.
5d: Coordinate response to FDA requests for information during approval process : Ongoin g. LTC David Shoemaker, Marieann Brill and "Decision Gate" are all involved in USAMMDA's sponsorship of this project and the creation/maintenance of a FDA compliant medical monit oring program for the 3 clinical sites in Phase 2. As a result, this Phase 2 study will be permissible for inclusion in the "burden of proof" submission for our ultimately new FDA 510k approved indication.
5e: Insure mandatory reporting to SAMMC, ISR & USAMRMC is maintained: Ongoing and in good standing.
TASK 6. Future Research Endeavors
At the comp letion of Tasks 1-5 we will have a publically available, FDA-approved mo nitoring device with solid basic science and initial clinical research support. The main outcome of this task is to start the next step, which is the creation and validation of NIRS-base clinical guidelines for the diagnosis and treatment of acute compartment syndrome to support a new FDA indication for the Nonin Equinox TM as a DIAGNOSTIC device, on top of its currently approved monitoring indication. This task requires clinical investigational trials that will follow the conclusion of this grant.
PROBLEM AREAS
Sensors not picking up signal on some injured legs Issue: We have discovered that on certain subjects the sensors on the injured leg are unable to pick up or maintain a signal that is usable by the Nonin 7600 Monitor. Our current belief is that this is because the amount of light reflected back to the sensors or the ca lculated percent oxygenation fall outside certain thresholds. Based on prior indications for the device, the monitor's analysis algorithm interprets this as a problem in the system such as the sensor becoming detached from the pod, or loss of integrity in the application of the sensor to the patie nt. An error message is generated and an oxygenation value is not displayed or recorded. The error messages can be mechanical (i.e. the sensor wire disengages from the pod) and when they are, the y can be resolved by checking the sensor's connection to the pod and patient, sometimes necessitating replacing the sensor. However, we have encountered cases where regular troubleshooting of the system according to Nonin procedures and including replacement of sensors has not rectified the problem. A usable signal cannot be obtained in these cases.
Resolution:
We have been working diligently with Nonin to resolve this issue. Just prior to the close of this reporting period Nonin had presented a solution where a different monitor -the 7610, could be used to capture individual raw wavelength data, a robust amount of information that is not displayed or recorded by the 7600 oximeter. The 7610 oximeter uses the same sensors (i.e. p atient interface) as the 7600, but it records all light data in its raw state, to allow for thorough investigation of the source of error messages, that do not resolve with troubleshooting measures aimed at mechanical problems. It is a USB connection into a laptop running the Nonin data collection software, rather than into a dedicated monitor. All 12 sensors will remain in place on the subject. The sensor(s) that is generating the error will be plugged into the 7610 oximeter while the others w ill remain connected to the 7600 oximeter. This setup will temporarily replace the trunk cable and 7600 monitor display and will allow the oximetry pods to capture additional wavelength data which is stored on the laptop. This process needs to only collect 1-2 minutes of data. T hen the patient is reattached to the standard 7600 set-up.
Using the 7610 will have no effect on the subject's participation in the study since it uses the same sensors as the 7600 model. The sensors do not need to be replaced. The only difference between the two monitors is that the 761 0 model captures raw wavelength data, while the 7600 model does not. Collecting wavelength data using the 7610 monitor will allow greater detail of information and flexibility in the analysis of tissue oxygenation levels.
Although the 7610 oximeter has not been cleared by the FDA, its intended use, indications for use, and the associated risks of the monitor are consistent with those associated with the 7600 model, which is being studied as an investiga tional device under this protocol. Both are integrated, digital devices for measuring regional hemoglobin oxygen saturation of blood underneath the sensor. They are used to monitor critical organ health, specifically of the cerebral cortex, allowing early intervention to prevent ischemia.
Progress: At the end of the reporting period, a protocol amendment had been prep ared to include the use of the 7610 oximeter, and this had be en submitted to our USAMMDA regulatory personnel for review ahead of submitting the amendment to the respective IRBs. Nonin had modified the 7610 device and laptop such that it could be used in the study. They will be bringing the device to Atlanta and will train the coordinators on its use in mid October. The regulatory approvals allowing use of this device should be in place by the middle of November. Further, we have already added locking mechanisms to the pods, that prevent the most common mechanical error, which is the sensor disengaging from the pods. 
CONCLUSIONS
Significant progress has been made during the third year of this award and we are on course for completing our commitments on time by the end of the upcoming fourth year. The Phase 2 clinical study, originally planned to be conducted in Afghanistan and Iraq, was succe ssfully transitioned to an FDA-regulated study to be conducted at three civilian trauma centers in the state of Georgia -Grady Memorial Hospital, Atlanta Medical Center and Athens Regional Medical Center. During the year we received approvals to conduct the study at these sites from the respective local IRBs and from the USAMRMC's Human Protections Office. Research teams were established and trained, and patient screening and subject e nrollment commenced. At the end of the reporting period we had enrolled 44.2% of the subjects required by the protocol.
Data from the initial animal studies that were completed in the previous year was analyzed and presented at four conferences. A manuscript has also been prepared. Based on the successful outcome of that study, an additional study was designed using a different model of porcine compartment syndrome. During this year, the protocol was prepared and received approval from the UGA IACUC and the USAMRMC ACURO. The study was initiated and completed. Nine animals were used in the study and usable data was captured from seven animals. We have one final study planned, for the 4 th period and are currently seeking an extension for this period.
We have had to overcome many unforeseen hurdles in the execution of this award, most particularly in relation to the USAMRMC's decision that this study needed to be conducted as an FDA-regulated study which required its transition from the military theater in Afghanistan and Iraq to the civilian setting in the USA. This transition consumed 12 months of valuable performance time, which necessitated a one year extension of the performance period. We have worked diligently over the la st year to ensure that the study was established in Georgia according to FDA requirements such that the data can be used to support an FDA regulatory submission. The study is now well underway and we expect to have subject enrollment completed within the third quarter of the upcoming fourth year of this award.
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NIRS VERSUS DIRECT PRESSURE MONITORING OF ACUTE COMPARTMENTAL SYNDROME IN A PORCINE MODEL Brett A. Freedman, MD
Lieutenant Colonel, U.S. Army Medical Corps PURPOSE: Assess the correlation of near infrared spectroscopy (NIRS) and tibial intracompartmental perfusion pressure (TIPP) in a porcine model of acute compartment syndrome (ACS). DESIGN: Animal research POPULATION STUDIED: 31 Landrace swine (16 control; 15 acute trauma). METHOD: Pigs were positioned in dorsal recumbency, and maintained on isoflurane with positive pressure ventilation. A median saphenous artery was catheterized for direct arterial pressure measurement. On each tibia, a NIRS sensor (Nonin, Plymouth, MN) was centered over the craniolateral muscle compartment. On the test leg, two 18-gauge needles were centered on each side of the sensor for direct pressure transducer measurement of TICP. For infusions, 5% albumin was infused through 2 18-gauge needles to elevate tibial intra-compartmental pressures (TICP). A single 18-gauge needle lateral to the midpoint of the NIRS sensor on the control leg monitored TICP. Continual time synchronized blood pressure (BP) measures of systolic (SAP), diastolic (DAP), and mean pressures (MAP), pulse rate (HR), respiratory rate (RR), systemic pulse oximetry (pulse ox), body temperature (T), TICP, and NIRS from each leg were measured. For the control group (N=16), transducers were zeroed and TIPP ([=DBP -TICP]) of the test leg was incrementally increased by albumin infusion. Continuous measurements (NIRS, BP, HR, RR, pulse ox, T) were taken at baseline for 10 min, and then for 5 min each at TIPP=40, =30, =20, and =10 mmHg, and then 10 min each at TIPP=0 mmHg, =MAP, =SAP and =SAP+10 mmHg. Fasciotomies were then performed bilaterally and measurements were recorded for 10 min. For the trauma group (N=15), baseline measurements were obtained for 10 min after which sensor and needle placement was marked and then removed from the test leg. The limb was stabilized and trauma induced by dropping a 2 kg weight 30 times down a 100 cm cylindrical tube over the craniolateral aspect of the limb. Instrumentation was replaced, a 45 min equilibration period observed, and infusion protocol performed as described above. DATA ANALYSIS: For each group, repeated measures ANOVA tested for differences in TICP, TIPP and NIRS. Tests were 2-sided with α<0.05 considered significant. Pearson's correlations were calculated between TICP and NIRS, and TIPP and NIRS. FINDINGS: TICP was significantly higher for the test versus control limb at all time-points except TIPP=40 mmHg and >5 min following fasciotomy. NIRS detected significant changes in tissue oxygenation at all time points in which TICP was significantly elevated. Once TIPP reached 20mmHg, NIRS decreased significantly from baseline and did not return to baseline levels until >5 min after fasciotomy. NIRS detected decreased oxygenation at each interval of TIPP decrease and a subsequent increase following fasciotomies. Significant negative correlations of TICP and NIRS and positive correlations of TIPP and NIRS were observed. CONCLUSIONS: NIRS provided a reliable, sensitive measure correlating to both an increase and decrease in TICP and TIPP, respectively in this model; acute trauma did not alter the strength of correlation between NIRS values and TICP or TIPP. IMPLICATIONS: Further research is needed to determine at what NIRS reading a fasciotomy may be indicated to prevent permanent tissue damage. FROM/TO TIME PERIOD: Data 
SUMMARY:
This study aimed to correlate near infrared spectroscopy (NIRS) values and the tibial intracompartmental perfusion pressure (TIPP).Compartment pressures were manually elevated and continually monitored using NIRS. This study provides data that establishes a correlation between NIRS measurement of hemoglobin oxygen saturation and TIPP.
OBJECTIVE:
Near Infrared Spectroscopy (NIRS) has been proposed to provide continual, real time, non-invasive monitoring of traumatized extremities. The aim of this study was to correlate NIRS values and tibial intra-compartmental perfusion pressure (TIPP) in a porcine model of acute compartment syndrome.
METHODS:
In 16 swine, TIPP of the test leg was increased incrementally by albumin infusion and measured at predetermined intervals. 
RESULTS:
The model successfully created consistent, reproducible increases in TICP and decreases in TIPP. Significant increases in TICP between test and control limbs at all time points with the exception of TIPP of 40 mHg and at 5 and 10 minutes following fasciotomies were found ( Figure 1 ). Concurrently, NIRS was able to detect significant changes in tissue perfusion at all time points. There was a significant negative correlation of TICP and NIRS measurements (r=-0.79, p<0.0001). NIRS was able to detect increased tissue oxygenation following pressure relieving fasciotomy.
CONCLUSION:
NIRS of the compartment provided a reliable, sensitive measure correlating to both an increase in TICP and a decrease in TIPP in this porcine tibial model. Additionally, a release in pressure through fasciotomy resulted in a predictable return to normal NIRS values. Measurements were taken at baseline for 10 min, TIPP=40, 30, 20, and 10 mmHg for 5 min each, TIPP=0 mmHg for 10 min, TIPP equal to MAP for 10 min, SAP for 10 min and SAP+10 mmHg for 10 min. Fasciotomies were then performed and measurements taken for 10 additional min. All pigs were euthanized at the end of the experiment. For the acute trauma group, instrumentation was marked and removed from the test leg after the 10 min baseline period. The limb was stabilized and trauma induced by dropping a 2kg weight 30 times down a 100 cm high cylindrical tube on the craniolateral compartment. Instrumentation was replaced and a 45 minute equilibration period observed before the infusion protocol was performed as described above. The contralateral (nontraumatized) leg was used as an internal control. For each group, a repeated measures ANOVA model, including factors for group, time, and group by time interaction, tested for differences in TICP, TIPP and NIRS values. All tests were 2-sided with α<0.05 considered significant. Pearson's correlations were calculated between TICP and NIRS, and TIPP and NIRS. Results: Both models created consistent, reproducible increases in TICP and decreases in TIPP. Significant increases in TICP between test and control limbs were found at all time points except TIPP=40mmHg and 5 and 10 min following fasciotomies. NIRS was able to detect significant changes in tissue oxygenation at all the same time points. All TICP of the test leg increased significantly from baseline except for 10 min following fasciotomy. Once TIPP reached 20mmHg, NIRS decreased significantly from baseline and did not return to baseline levels until 5 and 10 min after fasciotomies. NIRS was able to detect decreased oxygenation at every TIPP decrease and subsequent increase following fasciotomies. TIPP was significantly different than baseline at all time points until 5 min after fasciotomies. For the control group, transducers were zeroed and TIPP of the test leg was incrementally increased by albumin infusion. Measurements were taken at baseline for 10 min, TIPP=40, 30, 20, and 10 mmHg for 5 min each, TIPP=0 mmHg for 10 min, TIPP equal to MAP for 10 min, SAP for 10 min and SAP+10 mmHg for 10 min. Fasciotomies were then performed and measurements taken for 10 additional min. All pigs were euthanized at the end of the experiment. For the acute trauma group, instrumentation was marked and removed from the test leg after the 10 min baseline period. The limb was stabilized and trauma induced by dropping a 2kg weight 30 times down a 100 cm high cylindrical tube on the craniolateral compartment. Instrumentation was replaced and a 45 minute equilibration period observed before the infusion protocol was performed as described above. The contralateral (non-traumatized) leg was used as an internal control. For each group, a repeated measures ANOVA model, including factors for group, time, and group by time interaction, tested for differences in TICP, TIPP and NIRS values. All tests were 2-sided with α<0.05 considered significant. Pearson's correlations were calculated between TICP and NIRS, and TIPP and NIRS. Results: Both models created consistent, reproducible increases in TICP and decreases in TIPP. Significant increases in TICP between test and control limbs were found at all time points except TIPP=40mmHg and 5 and 10 min following fasciotomies. NIRS was able to detect significant changes in tissue oxygenation at all the same time points. All TICP of the test leg increased significantly from baseline except for 10 min following fasciotomy. Once TIPP reached 20mmHg, NIRS decreased significantly from baseline and did not return to baseline levels until 5 and 10 min after fasciotomies. NIRS was able to detect decreased oxygenation at every TIPP decrease and subsequent increase following fasciotomies. TIPP was significantly different than baseline at all time points until 5 min after fasciotomies. Purpose Near infrared spectroscopy (NIRS), a noninvasive means for monitoring muscle oxygenation, may be useful in the diagnosis of acute compartment syndrome, a condition characterized by poor tissue perfusion. This study used the decrease in muscle oxygenation caused by exercise to investigate the ability of anatomic placement of NIRS sensor pads over compartments of the forearm to isolate perfusion values of a specific compartment.
Methods
We recruited 63 uninjured volunteers from a private clinic-based setting and placed NIRS sensor pads over the dorsal, volar, and mobile wad compartments of 1 forearm. A total of 49 participants also had the contralateral forearm monitored, which served as an internal control. Participants performed a series of 3 exercises designed to sequentially activate the muscles of each compartment. A washout period separated each exercise to allow perfusion to return to baseline. We compared NIRS values of each compartment recorded during muscle contraction with baseline values.
Results
Mean NIRS values decreased significantly from baseline during muscle contraction for all compartments, whereas mean NIRS values of muscle compartments that remained at rest showed little or no change. We observed no changes in NIRS values of the contralateral arm, which remained at rest during the entire data collection period. A CUTE COMPARTMENT SYNDROME (ACS), a condition that results from inadequate perfusion in an injured extremity, causes devastating sequelae if not promptly diagnosed and treated. To date, the only objective diagnostic technique available to clinicians is intramuscular pressure measurement. However, these measurements are invasive and painful, and if performed incorrectly may yield unreliable results. [1] [2] [3] Near infrared spectroscopy (NIRS)-based tissue monitors use differential light absorption characteristics to provide a noninvasive, continuous means to quantify the proportion of hemoglobin saturated with oxygen in tissue 2 to 3 cm beneath the skin. 4 -7 The US Food and Drug Administration has validated and approved NIRS to monitor perfusion of cerebral and somatic tissue below the sensors. Near infrared spectroscopy is capable of passing through skin, soft tissue, and bone. The depth of penetration is directly proportional to the distance or separation between the light source and light receptor. 6, 7 With the sensor used in this study, complete absorption of light by large vessels and hematomas means that the light collected by NIRS sensors is light that is capable of passing through the microcirculation. 4 Because they allow for measurement of perfusion, the critical factor in compartment syndrome, devices using NIRS technology may be useful for detecting ACS.
Conclusions
Near infrared spectroscopy-based tissue perfusion monitors use noninvasive sensor pads that emit 1 to 4 beams of red light, which are used to measure muscle oxygenation. It is necessary to monitor each muscle compartment because a compartment syndrome can develop in one compartment and not another. Because these sensor pads are placed on the surface of the skin, proper placement is essential to obtain an accurate reading.
Previous studies 4,8 -10 have validated the responsiveness of NIRS to changes in muscle oxygenation of the forearm. However, for NIRS to be validated for clinical practice, it must also be demonstrated that pad placement produces the oxygenation values of the intended compartment without any cross-contamination or interference from neighboring compartments. To this end, we designed a study that sought to investigate the ability of NIRS to determine whether measurements of muscle oxygenation in a single compartment can be determined independently of other compartments. We did this by measuring the decrease in tissue oxygenation caused by muscle contraction, 1 compartment at a time, while measuring the response in all compartments. We hypothesized that NIRS values of the activated compartment would decrease significantly from baseline, whereas the values of the compartments at rest would remain largely unaffected.
MATERIALS AND METHODS
The study population consisted of 63 uninjured volunteers between 18 and 75 years of age, who provided written informed consent in accordance with institutional review board approval. We recruited study participants using a mass e-mail that solicited volunteers from a pool of employees and members of the local community. Exclusion criteria included subjects with a diagnosis of peripheral vascular disease or pulmonary disease, or prior surgery of the forearm other than wrist surgeries such as carpal tunnel or first dorsal compartment release.
Once we enrolled subjects, we recorded their age, gender, race, and body mass index (BMI). We obtained NIRS values using an INVOS Cerebral Oximeter (Model 5100; Somonetics, Troy, MI). Values are displayed as the percentage of hemoglobin saturated with oxygen (rSO 2 ). Consequently, a higher reading indicates a higher tissue oxygenation level. The device was calibrated during manufacturing and did not need recalibration before use.
All patients lay in a supine position, and we placed NIRS sensors over the volar, dorsal, and mobile wad muscle compartments at the junction of the proximal third and middle third of each forearm, 7 to 10 cm from the elbow. We measured the volar compartment by placing a pad over the superficial flexor muscles. We accessed the dorsal compartment by palpating the ulna. Then, we placed a pad 1 to 2 cm dorsally, over the extensor carpi ulnaris muscle. To locate the mobile wad, we asked participants to flex the elbow while receiving resistance at the wrist to reveal the brachioradialis muscle. We placed a pad directly over the brachioradialis muscle. We obtained baseline rSO 2 values after participants had been at rest for 60 seconds to allow readings to stabilize. We did not specifically examine the pronator quadratus and deep flexor compartments in this study.
To sequentially isolate each of these 3 compartments, the participant was asked to perform exercises designed to activate the desired muscle group, resulting in a predictable decrease in muscle oxygenation. We tailored each exercise specifically to activate muscles of a specific compartment while muscles of other compartments remained at rest. All exercises were performed with the elbow resting on the examination table at a right angle and the shoulder at rest. The participant performed each exercise for 30 to 60 seconds, followed by a washout period of 60 seconds, to allow the subject's rSO 2 values to return to baseline.
To activate the volar compartment, we instructed subjects to flex the middle and ring fingers around a writing pen against resistance offered by a member of the research team, while relaxing the rest of the hand. The goal was to isolate and test the flexor digitorum superficialis (Fig. 1) . To activate the dorsal compartment, participants extended the wrist and fingers with the elbow bent at 90°, the palm faced toward the ceiling, and the fingers extended. This movement activated the extensor carpi ulnaris (Fig. 2) . To activate the mobile wad (brachioradialis), with the wrist facing medially, the participant flexed at the elbow against resistance supplied by an investigator, while keeping the hand and wrist relaxed (Fig. 3) . We instructed participants to give 75% effort during constant contraction for roughly 30 seconds.
Among a subset of patients, we monitored the contralateral upper extremity as well. The contralateral arm remained at rest during all muscle activation of the test arm. The contralateral side was validated previously as an internal control for NIRS monitoring in the lower extremity. 5 We calculated the response to muscle contraction for each compartment of the forearm as the change in rSO 2 values from baseline (rSO 2 value during muscle contraction minus rSO 2 value at rest). We tested mean differences between rSO 2 values at baseline and during muscle contraction for significance using the signed rank test and considered results to be statistically significant at PՅ.05. We assessed normality using the Anderson-Darling test.
RESULTS
Of 63 uninjured study participants, 52 were female. Most participants were nonsmokers (58 participants) and nondiabetic (61 participants). A total of 28 participants were of normal weight (BMI Ͻ 25), 15 were overweight (BMI between 25 and 29), and 19 were obese (BMI Ն 30). Table 1 presents the rSO 2 values for each compartment. All rSO 2 values of activated compartments decreased significantly from baseline during muscle contraction (PϽ.0001 for all compartments), whereas compartments at rest remained largely unchanged. Figure 4 shows perfusion data from each muscle compartment of a sample study participant throughout sequential muscle contraction and washout periods. Activation of each compartment is labeled with an arrow.
For 49 study participants, rSO 2 values were available for the contralateral forearm. Table 2 presents a comparison of rSO 2 values from each arm at baseline and after muscle activation of a given compartment. In the activated arm, rSO 2 values decreased by an average of approximately 25 percentage points during muscle contraction, whereas the average change in values from the contralateral arm was approximately 0.
We observed no differences in rSO 2 values by gender or BMI. The current study sample precluded stratification by diabetes or smoking status.
DISCUSSION
Near infrared spectroscopy provides the potential for noninvasive, continuous monitoring of tissue perfusion, which could provide a useful objective means of diagnosis of ACS. However, for this technology to be validated, one must be confident that anatomic placement of NIRS sensor pads on the surface of the skin produces values of the intended muscle compartment.
This study measured rSO 2 values during sequential contraction of muscles in each of the 3 traditionally recognized compartments of the forearm among 63 uninjured volunteers. The results suggest that the pad placement described here produces rSO 2 values that are both sensitive and specific to the intended compartment. During muscle contraction of each compartment, mean rSO 2 values decreased significantly from values taken while the participant was at rest, reflecting the decrease in tissue oxygenation induced by exercise. Moreover, mean rSO 2 values of surrounding (unstimulated) muscle compartments reflected little or no change, suggesting the ability of NIRS to produce measurements specific to the intended compartment. A subset of participants had both the activated and contralateral arms monitored. Whereas values of the test arm substantially decreased as a result of muscle contraction, mean values collected simultaneously from the control arm showed no clinically meaningful change. These results suggest that decreases observed during muscle contraction were not spontaneous, because we did not observe similar changes in the contralateral arm.
Owing to an amendment to data collection procedures, only 49 of the 63 subjects provided NIRS values from the contralateral arm; however, results from this subsample support the hypothesis that values of compartments of a forearm at rest remain stable.
One major obstacle in the validation of NIRS is the lack of another noninvasive method of measuring muscle perfusion. This precludes traditional validation of this technique against a reference standard or true value. Without such a true value, manipulation of muscle oxygenation of an isolated compartment is the only way to confirm that rSO 2 values produced belong to the intended compartment and not its neighbor. Nevertheless, there may have been some unintended activation of surrounding muscle groups, because it can be difficult for a participant to isolate a particular muscle. Furthermore, lack of a standard prevents traditional calculations of sensitivity and specificity rates; never- IQR, interquartile range. "Pre" and "Post" refer to rSO 2 values taken at baseline and after muscle contraction, respectively. Values are presented as percent oxygenation. theless, the results of this study demonstrate the concepts of sensitivity and specificity through the observed responses to exercise on activated and nonactivated muscle compartments, respectively.
This study provides evidence supporting further investigation of the use of NIRS as a noninvasive, continual monitoring tool for ACS of the forearm, but there are some inherent limitations to this application. There are reports of elevation of tissue pressures within subcompartments, the perfusion of which NIRS may not be capable of reading. In addition, the NIRS device used in this study measures oxygenation in the microcirculation 2 to 3 cm beneath the skin. Thus, it is plausible that subcutaneous fat exceeding 2 to 3 cm at the sensor site may impede the device's ability to obtain a reading. Although we encountered no such difficulties in this study, this concern warrants investigation in a future study. Moreover, because of complete light absorption in this particular device, NIRS is not currently capable of obtaining perfusion values in the presence of a hematoma; nevertheless, NIRS light is able to penetrate skin, soft tissue, and bone. Future studies should focus on the use of NIRS in a clinical setting to investigate and address these and other limitations. Over the last two decades, tissue oxygenation saturation (StO 2 ) measured by near infrared 65 spectroscopy (NIRS) has been extensively evaluated for use in determining systemic and 66 regional tissue perfusion (1) (2) (3) (4) . It is widely used, and validated for monitoring cerebral 67 oxygenation during anesthesia (5) (6) (7) . Recent efforts have focused on this use of NIRS in 68 assessing regional perfusion and more specifically regional perfusion in the setting of acute limb 
184
In both groups, the initial caudolateral fasciotomy was performed by sharp incision 185 caudolateral to the NIRS sensor from stifle to hock to a depth through all fascial layers of the 186 muscular compartment. In the control group, seven pigs did not have an immediate increase in 187 NIRS and a second fasciotomy was performed (Table 1) . Similarly, in the acute trauma group 188 eleven pigs received a second fasciotomy. Thus NIRS was able to detect decreased tissue 189 oxygenation at every perfusion pressure decrease and subsequent increase following pressure 
210
Data from this study suggests that NIRS may have a role in determining a threshold level 211 of a specific outcome measure that can assist the clinician's decision whether or not to perform a 212 fasciotomy. It was noted that NIRS values dropped significantly from baseline at a TIPP of 20 213 mm Hg or less in both the control and acute trauma test limbs. Thus, NIRS is able to detect 214 differences in oxygenation at TIPP considered to be diagnostic for ALCS and a threshold for 215 fasciotomy (16, 17) . While these data do not suggest nor document any effect on the muscle 216 tissue, they do provide evidence for a future avenue of work.
217
The data involving the fasciotomies also provided some interesting results. While there is 218 no way to know if the limbs that did receive a second fasciotomy would have had improved PP 219 and higher NIRS values over time without the second fasciotomy, the NIRS provided real time 220 data that could be used to assess if the initial fasciotomy was successful in releasing intra-221 11 Acute Porcine Compartmental Syndrome Model compartmental pressure and restoring muscle perfusion. This finding has implications as a 222 potential use of NIRS intra-operatively as a quality control device to insure adequate release of 223 the compartments to prevent insufficient releases (15).
224
A second finding was that in limbs of both pigs groups where a second fasciotomy was 225 performed, TIPP could improve toward baseline initially without a NRIS change up to a certain 226 point. As shown in the results during this time, the NIRS was not changing and thus the decision 227 to perform the second fasciotomy was made. While current data documents there is a direct 228 relationship of TIPP to NIRS, the NIRS values may be more sensitive in the initial attempts at 229 compartmental decompression as it assesses the tissue oxygenation and not merely an arbitrary 230 change in pressure.
231
A second point of potential difference between current data and previous studies using Long dash from fasc 1 to fasc+5 represents data from pigs that did not have a second fasciotomy. Table 1 : NIRS and perfusion pressures from the two groups during the fasciotomy portion of the experiment.
